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Background: A multimodal and preventative approach to providing postoperative analgesia is becoming
increasingly popular for children and adults, with the aim of reducing reliance on opioids. We conducted a
prospective, randomized double-blind study to compare the analgesic efficacy of intravenous paracetamol
and dipyrone in the early postoperative period in school-age children undergoing lower abdominal surgery
with spinal anesthesia.
Methods: Sixty children scheduled for elective lower abdominal surgery under spinal anesthesia were randomized
to receive either intravenous paracetamol 15 mg/kg, dipyrone 15 mg/kg or isotonic saline. The primary outcome
measure was pain at rest, assessed by means of a visual analog scale 15 min, 30 min, 1 h, 2 h, 4 h and 6 h after
surgery. If needed, pethidine 0.25 mg/kg was used as the rescue analgesic. Time to first administration of rescue
analgesic, cumulative pethidine requirements, adverse effects and complications were also recorded.
Results: There were no significant differences in age, sex, weight, height or duration of surgery between the
groups. Pain scores were significantly lower in the paracetamol group at 1 h (P = 0.030) and dipyrone group at 2 h
(P = 0.010) when compared with placebo. The proportion of patients requiring rescue analgesia was significantly
lower in the paracetamol and dipyrone groups than the placebo group (vs. paracetamol P = 0.037; vs. dipyrone
P = 0.020). Time to first analgesic requirement appeared shorter in the placebo group but this difference was not
statistically significant, nor were there significant differences in pethidine requirements, adverse effects or
complications.
Conclusion: After lower abdominal surgery conducted under spinal anesthesia in children, intravenous paracetamol
appears to have similar analgesic properties to intravenous dipyrone, suggesting that it can be used as an
alternative in the early postoperative period.
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Acute pain is one of the most unpleasant experiences
of childhood, and is generally a consequence of injury,
illness, or medical intervention [1]. Acute pain management
in children is increasingly characterized by multimodal
or preventative approaches. The former comprises a
combination of drugs and techniques such as non-steroidal
anti-inflammatory drugs (NSAIDs), opioids, paracetamol,
and regional or neuraxial anesthesia.
During the last three decades, spinal anesthesia has
become increasingly popular in pediatric practice, but its
use is not universal and some patients, anesthesiologists
and surgeons still prefer general anesthesia. Nonetheless,
spinal anesthesia is an easy and effective technique that
provides highly effective analgesia, and sympathetic and
motor block in the lower part of the body [2].
Single-shot intrathecal blocks have a limited duration
of action, depending on the local anesthetic agent used.
Therefore, a combination of other analgesics is required
to treat pain when the spinal block wears off. These
include opioids, non-opioids, and adjuvant drugs. Opioids
are often used to treat moderate to severe pain in children;
however, their use is limited by undesirable side effects
such as cardiovascular, central nervous system and re-
spiratory depression, itching, urinary retention, and nausea
and vomiting [3].
Many studies in adults and children have shown that
non-opioid analgesics such as paracetamol, NSAIDs, and
dipyrone exhibit an opioid sparing effect and improve
the quality of postoperative analgesia [4]. Paracetamol is
the most commonly used analgesic to treat mild and
moderate postoperative pain in children [1]; an intraven-
ous formulation is now available. Dipyrone is a pyrazoline-
derived analgesic drug with antipyretic, anti-inflammatory,
and spasmolytic properties. The reliability and efficiency
of intravenous paracetamol has been demonstrated in
several clinical studies [5-7], and some have compared the
antipyretic effectiveness of paracetamol with dipyrone in
young children with fever [6,7].
The aim of this study was to assess the analgesic effect
of intravenous paracetamol and dipyrone for postoperative
pain relief in children undergoing spinal anesthesia for
lower abdominal surgery.
Methods
The Institutional Ethics Committee of Baskent University
Faculty of Medicine approved the study protocol [Project
no: KA 09/06]. Written, informed consent was obtained
from the parents or guardians of each patient. A total of
63 healthy, ASA physical status I and II children, aged 8 to
15 years, undergoing elective lower abdominal surgery
were enrolled in this study. Exclusion criteria included
any known contraindication for spinal anesthesia, such
as increased intracranial pressure, hemorrhagic diathesisand infection at the puncture site. Those with a known
history of allergy to the study drugs were excluded.
Intraoperative monitoring consisted of non-invasive
blood pressure measurement, electrocardiogram, pulse
oximetry, and end-tidal carbon dioxide measurement
using a nasal adapter. After peripheral intravenous access
had been obtained, an infusion of 0.45% NaCl in 5%
glucose was administered at 5 ml/kg/h. All patients had
been premedicated with intravenous midazolam 0.05 mg/kg
before lumbar puncture and supplemental oxygen 3 l/min
was administered. Children who were anxious or felt
uncomfortable after premedication or during surgery
received further sedation with intravenous boluses of
propofol 0.5–1.0 mg/kg.
Lumbar puncture was performed with the children in the
lateral decubitus position with the midline approach with a
26-gauge spinal needle (Atraucan; Braun, Melsungen,
Germany) at the L4–5 intervertebral space. After free
flow of CSF was observed, 0.3 mg/kg 0.5% hyperbaric
bupivacaine was injected. The extent of sensory block
was tested with a pinprick method, and the degree of
motor blockade was assessed using the modified
Bromage scale [6,8].
The children were randomized to one of three groups
according to a pre-generated randomization scheme cre-
ated by the web site Randomization.com.
(http://www.randomization.com).
After spinal anesthesia, children in Group Paracetamol
received intravenous paracetamol (Perfalgan™ Bristol-Myers
Squibb GmbH, München, Germany) 15 mg/kg premixed
with 0.9% NaCl to a total of 50 ml. Group Dipyrone
received intravenous dipyrone (Adepiron®, Adeka, Istanbul,
Turkey) 15 mg/kg premixed with 0.9% NaCl to a total
of 50 ml. The placebo group, received 50 ml 0.9% NaCl
intravenously (Figure 1). All study drugs had been pre-
pared by a researcher (MS) blinded to the treatment
protocol, and were administered using identical infusion
pumps over 15 min by another researcher (AK) blinded to
the content of the infusion.
Intraoperative hemodynamic data, operation types,
duration of surgery and degree of motor blockade were
recorded. After surgery, the children were transferred
to the post-anesthesia care unit (PACU), and the time
taken for the block to recede by two segments was
recorded. A consultant anesthetist (EC) blinded to the
group to which each patient had been assigned performed
all subsequent assessments.
The intensity of postoperative pain at rest was assessed
using a visual analog scale (VAS) (where 0 represented
no pain and 10 the worst pain ever experienced) at 15
and 30 minutes, and 1 h, 2 h, 4 h and 6 h after surgery.
Pain at rest was the primary outcome measure.
Each patient’s sedation level was measured using a
graded scale (0 = fully awake, 1 = awake but drowsy, 2 =
Figure 1 Flow chart of the study design.
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sleeping, not arousable) at the same time. Postoperative
pain was treated according to the same protocol in all
groups. Intravenous pethidine 0.25 mg/kg was adminis-
tered as rescue analgesia when VAS exceeded 4 out of
10, until the pain score was less than 4 or to a total
dose of 1 mg/kg. Time to first administration of pethidine
and cumulative pethidine consumption during the first six
postoperative hours were recorded as secondary outcome
measures.
Sedation levels, and all adverse effects including
hypotension (>20% decrease in systolic blood pressure
from baseline), bradycardia (heart rate <60 beats/min),
respiratory depression, and nausea or vomiting were
recorded and treated until the child was discharged.
Children were discharged from the PACU when they
were fully awake, hemodynamically stable, breathing
satisfactorily and able to flex their hips. The time taken
to be ready for PACU discharge was also recorded.
Statistical analysis
A priori power analysis was performed based on the
likely difference in the subjects’ postoperative pain scores
evaluated by VAS. Sample size calculation was informedby the findings of a study previously undertaken at our
institution [9], which indicated a likely 30% reduction in
pain scores reported by subjects receiving an analgesic
drug compared with placebo. We identified that the
highest pain scores tended to be reported 2 h after surgery,
equating to a maximum difference between means of
14 mm on the VAS with a standard deviation (SD) of
15 mm. Assuming a two-tailed type I error α = 0.05 and a
power of 0.80, a priori analysis suggested 19 patients
would be needed in each group (Power and Precision™
Biostat Inc., Englewood, NJ). All subsequent statistical
analyses were performed using SPSS for Windows soft-
ware (Statistical Package for the Social Sciences, version
17.0, SSPS Inc., Chicago, IL, USA). The analysis of
variance test (ANOVA) was used for numerical and
continuous variables to assess differences between groups.
Homogeneity of variances was calculated using Levene’s
test and Lilliefors significance correction. Post hoc ana-
lyses were performed with the Bonferroni test. Either
the chi-square or Fisher’s exact test was used to analyze
categorical variables when appropriate. Data are pre-
sented as mean ± SD, median with range or number
of cases. A P value <0.05 was considered statistically
significant.







Sex (male/female) (n) 20 / 0 18 / 2 17 / 3
Age (years) 8 (7-15) 8 (7-13) 8 (7-15)
Weight (kg) 26 (20-60) 26,5 (20-50) 30 (20-51)
Height (cm) 136 (124-160) 130 (120-158) 132 (115-158)
Duration of surgery 40.7 ± 11.6 44.5 ± 13.7 42 ± 12.9
Type of surgery (n)
Circumcision 8 8 7
Inguinal herniorrhaphy 4 4 4
Hydrocoelectomy 1 2 3
Orchiopexy 3 2 3
Hypospadias repair 1 2 2
Phlenoidal sinus 1 1 2
Varicocele 2 2 1
Data are expressed as medians (minimum-maximum) for age, weight and
height, absolute numbers for gender and type of surgery, and mean ± standart
deviation for duration of surgery.
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Sixty-three patients were invited to participate. During
screening, two patients were found not to meet the
inclusion criteria, and one patient’s parents declined
consent. A total of 60 patients constituted the study
population (Figure 1). There were no statistically sig-
nificant differences between the groups with regard to
age, sex, weight, type of operation, duration of surgery,
or anesthesia (Table 1).
Visual analogue scale (VAS) scores were statistically
significant between Group Paracetamol and the placebo
group after 1 hour (p = 0.030) and between Group DipyroneFigure 2 Visual analog pain scores in the first 6 h after surgery. Value
placebo, #P = 0.010 dipyrone versus placebo.and the placebo group after 2 h (p = 0.010). There was
no statistically significant difference in pain scores at
any other times. The pain scores recorded on emergence
from spinal anesthesia and in the first 6 hours after
surgery are shown in Figure 2.
The number of patients who received rescue analgesia
was significantly lower for the Paracetamol and Dipyrone
groups compared with the placebo group (paracetamol
versus placebo, p = 0.037; dipyrone versus placebo, p =
0.020) (Table 2). Intravenous pethidine was given to 14
(70%) patients in the Paracetamol group, 12 (60%) in
the Dipyrone group and 19 (95%) in the placebo group
(Figure 3).
The mean time to administration of rescue analgesia
was 2.9 ± 1.3 h in the Paracetamol group, 2.1 ± 1.5 h in
the Dipyrone group, and 1.8 ± 1.3 h in the placebo group,
but these differences were not statistically significant
(Table 2). There were also no significant differences in
cumulative pethidine consumption or sedation scores be-
tween the three groups at any time point. Duration of stay
in and time to meet the discharge criteria for the PACU,
and time taken for regression of the sensory block and
recovery of the motor block were broadly similar between
the groups. There were no significant changes in hemo-
dynamic parameters from baseline in either active treat-
ment group. No episodes of hypotension or respiratory
depression were recorded intraoperatively or in the PACU.
Bradycardia was observed in two patients in each group
(Table 3). There were also no significant differences in the
incidence of postoperative nausea, vomiting, requirement
for antiemetic rescue medication or any other peri-
operative adverse events between the groups (Table 3).
No episodes of agranulocytosis were reported.s shown are mean ± standard deviation. *P = 0.030 paracetamol versus
Table 2 Intraoperative parameters in each groups
Paracetamol (n = 20) Dipyrone (n = 20) Placebo (n = 20)
Number of patients requiring additional sedation 7 8 9
Local anesthetic volume (ml) 1.7 ± 0.6 1.6 ± 0.4 1.8 ± 0.5
Time to two segments regression of block (min) 75 ± 15 74 ± 12 73 ± 14
Number of patients requiring rescue analgesia n (%) 14*(70%) 12#(60%) 19 (95%)
Time to first dose of rescue analgesic (hour) 2.9 ± 1.3 2.1 ± 1.3 1.8 ± 1.3
Total dose of rescue analgesic (mg) 9.5 ± 5.9 10 ± 3.4 10.6 ± 4.7
Time to ready for discharge from PACU (min) 75 ± 18 74 ± 21 72 ± 24
Data are expressed as mean ± standart deviation and absolute number of cases (n). *P =0.037 paracetamol versus placebo, #P = 0.020 dipyrone versus placebo.
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We evaluated the efficacy of intravenous paracetamol
and dipyrone for administered as postoperative analgesia
after day-case lower abdominal surgery in children. We
found that postoperative pain scores were significantly
lower in the active treatment groups in the first and
second postoperative hours when compared with placebo,
but there were no statistical differences in pain scores
between the three groups at other times. We also found
that the proportion of patients requiring rescue analgesia
was significantly lower in the active treatment groups
compared with placebo; however, there were no statistical
differences in cumulative analgesic consumption.
The historic view that young children neither respond
to, nor remember, painful experiences to the same degree
as adults is no longer thought to be true [1]. Most pre-
mature neonates are capable of experiencing pain, and
under treatment of pain results in harmful physiological
and behavioral responses that have long-lasting negative
consequences on the developing nociceptive systems
[8,10]. Mather and Mackie [11] reported that 40% of
children undergoing surgery experienced moderate to
severe postoperative pain, and that 75% received inad-
equate pain treatment [12,13].Figure 3 Rescue analgesic requirements in the first 6 h after surgery.
*P = 0.037 paracetamol versus placebo, *P = 0.020 dipyrone versus placebo.It has been reported that providing inadequate analgesia
to infants, preverbal children, and adolescents results
not only in short term physiologic disturbance but also
longer term behavioral changes, particularly during im-
munization [10,14,15]. It is now recognized that optimal
postoperative pain management is essential for children,
and that this should begin before surgery by providing
children and their parents with information about the
planned surgical procedure [16].
Treatments for postoperative pain include drugs such
as opioids, NSAIDs, paracetamol and dipyrone, as well
as regional anesthetic techniques such as spinal and caudal
anesthesia. The provision of adequate pain control
must be balanced against the risk of the side effects of
analgesics.
Neuraxial anesthesia in children is safe, provided ap-
propriate care and attention are paid. Spinal anesthesia
modifies the neuroendocrine stress response, ensures a
more rapid recovery, and may shorten hospital stay with
fewer opioid-induced side effects [17]. Furthermore, spinal
anesthesia provides profound analgesia with minimal
physiologic perturbations or side effects [17], and there
is a growing interest in using the technique for surgery
in preschool and school aged children [18]. Most studiesValues are shown are number and proportion. h: postoperative hours.







Hypotension 0 0 0
Bradycardia 3 3 3
Nausea 3 3 4
Vomiting 2 2 2
Respiratory depresion 0 0 0
Urinary retention 0 0 0
Data are presented as number of patients (n).
Caliskan et al. BMC Anesthesiology 2013, 13:34 Page 6 of 8
http://www.biomedcentral.com/1471-2253/13/34in these populations have focused on specific procedures;
none has examined the efficacy of paracetamol or dipyrone
for pain relief after spinal anesthesia has worn off.
The main limitation of spinal anesthesia is the variable
and relatively short duration of the block obtained with
a single-shot local anesthetic injection technique [2].
Adding parenteral or enteral analgesic drugs such as
opioid or NSAIDs is one means of overcoming these
problems and thereby increasing the quality and duration
of analgesia. Opioids are often used to provide effective
postoperative analgesia; however, undesirable side effects
may frequently be observed as a consequence of their
use. Ideally a non-opioid analgesic such as paracetamol,
an NSAID or dipyrone should be used to provide effective
pain relief to minimize the need for opioids [19]. The
safety of analgesic therapy has improved considerably
as this multimodal opioid-sparing approach has been
adopted; however, there are limited data concerning the
efficacy of these regimes in the early postoperative
period after surgery in children [20].
Paracetamol is commonly used as an analgesic and
antipyretic in pediatric practice. It primarily acts centrally,
where it is a potent antipyretic and mild analgesic. In
recent years, an intravenous formulation has been
introduced, and its safety and pharmacokinetic profile have
been established for children as young as 1 month of age
[12,21]. Dipyrone, a pyrazoline derivate, has antispasmodic,
antipyretic and anti-inflammatory effects. It is widely used
as an injectable non-opioid analgesic in several European
and South American countries, where it has gained
popularity due to the low incidence of adverse reactions
(although like some other opioids it carries a low risk
of agranulocytosis) [22]. Grundmann and colleagues stated
that very large prospective studies would be needed
to determine the true incidence of agranulocytosis [23]. A
study comparing the adverse effects of paracetamol,
diclofenac, aspirin and dipyrone reported that dipyrone
was relatively well tolerated and shared many of the
potential side effects of NSAIDs [22]. In our study, no
incidences of agranulocytosis were reported.
Paracetamol may be preferred to dipyrone in children
owing to its equal analgesic potency and lower risk ofadverse effects. Several clinical studies have confirmed
that the analgesic efficacy of intravenous paracetamol is
comparable with that of NSAIDs or dipyrone in ortho-
pedic, abdominal, and breast surgery in adults [22,24,25].
Landwehr and colleagues [24] reported that dipyrone
and paracetamol had similar analgesic potencies after
retinal surgery, whereas Grundmann and colleagues [23]
demonstrated that the analgesic potency of dipyrone was
superior to paracetamol during the first two postoperative
hours after lumbar disc surgery. To date, the only study
comparing the use of paracetamol with dipyrone in
children examined their antipyretic properties [6]. Ours
is the first study to examine their analgesic properties,
and found that they have broadly similar efficacy in the
first six hours after lower abdominal surgery in children.
Various studies have compared the analgesic efficacy
of intravenous paracetamol with other analgesic agents
such as tramadol, NSAIDs, and pethidine in children
[5,19]. Alhashemi and colleagues reported that intravenous
paracetamol was as efficient an analgesic as intramuscular
pethidine in children undergoing tonsillectomy [19].
Paracetamol provided significantly greater analgesic effect
than a placebo after orthopedic surgery in children
[26], and a relatively large intravenous dose improved
pain control after major spinal surgery in children and
adolescents [27].
Our results demonstrate that paracetamol and dipyrone
provide effective and comparable analgesia 1 h and 2 h
after surgery, respectively, based on a lower and equivalent
VAS scores compared with placebo. Although more
patients in the placebo group required rescue analgesia,
pain scores and cumulative pethidine consumption in
the three groups were not significantly different in the
first six postoperative hours. This concurs with the
findings of Cakan and colleagues, who found that paraceta-
mol 1 g administered intravenously at the end of surgery
and 6 hourly thereafter did not reduce opioid requirements
but improved the quality of pain relief [28].
A possible explanation for these findings might be that
the sample size in our study was not large enough to
detect subtle differences. Our power analysis was based
on the assumption that detecting a 30% decrease in
pain score on a VAS was clinically relevant and should
be our primary outcome measure, but this might not
be sufficiently large to detect pethidine consumption.
This might also explain the lack of a significant difference
in time to first analgesic requirement. It is notable that
in previous studies of the use of bupivacaine for spinal
anesthesia in children, the time to first analgesic require-
ment in the placebo group was 168 ± 70 min, which was
broadly similar to our findings [29]. It is likely that in
some patients the spinal anesthesia was still effective in
the early postoperative period. It has been suggested
that if the duration of preemptive analgesia extends
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pain hypersensitivity can be avoided [3]. Also, the
provision of pethidine as rescue analgesia is likely to
have influenced the subsequent low pain scores in all
groups.
In our opinion, both paracetamol and dipyrone can be
considered effective and equipotent analgesics in the
early postoperative period, but that the small differences
when compared with placebo indicate that they both
only exert a mild effect.
The use of opioid analgesics is an important risk factor
for postoperative nausea and vomiting (PONV). A reduc-
tion in the amount of systemic opioids would be expected
to reduce the incidence of PONV and other common side
effects. In our study, the use of pethidine was significantly
lower in the paracetamol and dipyrone groups compared
with the placebo group, but there was no statistically
significant difference in the incidence of PONV between
the groups. This may be a consequence of broadly similar
cumulative pethidine doses administered to participants in
each group.
Conclusion
In conclusion, our study showed that preemptive adminis-
tration of intravenous paracetamol or dipyrone provided
effective pain control and reduced pethidine requirements
in the first and second postoperative hours compared with
placebo. Paracetamol appears to be at least as effective
as dipyrone for pain relief, and it can be recommended
as a viable alternative to dipyrone after lower abdominal
surgery in children.
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